Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radboud J Duintjer Tebbens

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Expert Review of Vaccines|May 4, 2012
Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessationKimberly M Thompson, Radboud J Duintjer Tebbens
The Journal of Infectious Diseases|October 16, 2014
Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessationRadboud J Duintjer Tebbens, Kimberly M Thompson
System Dynamics Review|September 23, 2021
Using integrated modeling to support the global eradication of vaccine-preventable diseasesRadboud J Duintjer Tebbens, Kimberly M Thompson
MDM Policy & Practice|October 6, 2018
Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine UseRadboud J Duintjer Tebbens, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 22, 2018
Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and AfghanistanRadboud J Duintjer Tebbens, Kimberly M Thompson
Future Microbiology|November 11, 2016
The potential benefits of a new poliovirus vaccine for long-term poliovirus risk managementRadboud J Duintjer Tebbens, Kimberly M Thompson
BMC Infectious Diseases|September 26, 2015
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needsRadboud J Duintjer Tebbens, Kimberly M Thompson
The Journal of Infectious Diseases|August 26, 2017
Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining TransmissionKimberly M Thompson, Radboud J Duintjer Tebbens
The Journal of Infectious Diseases|August 26, 2017
Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining SerotypesKimberly M Thompson, Radboud J Duintjer Tebbens
The Journal of Infectious Diseases|October 16, 2014
Modeling the dynamics of oral poliovirus vaccine cessationKimberly M Thompson, Radboud J Duintjer Tebbens
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Expert Review of Vaccines|May 4, 2012
Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessationKimberly M Thompson, Radboud J Duintjer Tebbens
The Journal of Infectious Diseases|October 16, 2014
Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessationRadboud J Duintjer Tebbens, Kimberly M Thompson
System Dynamics Review|September 23, 2021
Using integrated modeling to support the global eradication of vaccine-preventable diseasesRadboud J Duintjer Tebbens, Kimberly M Thompson
MDM Policy & Practice|October 6, 2018
Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine UseRadboud J Duintjer Tebbens, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 22, 2018
Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and AfghanistanRadboud J Duintjer Tebbens, Kimberly M Thompson
Future Microbiology|November 11, 2016
The potential benefits of a new poliovirus vaccine for long-term poliovirus risk managementRadboud J Duintjer Tebbens, Kimberly M Thompson
BMC Infectious Diseases|September 26, 2015
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needsRadboud J Duintjer Tebbens, Kimberly M Thompson
The Journal of Infectious Diseases|August 26, 2017
Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining TransmissionKimberly M Thompson, Radboud J Duintjer Tebbens
The Journal of Infectious Diseases|August 26, 2017
Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining SerotypesKimberly M Thompson, Radboud J Duintjer Tebbens
The Journal of Infectious Diseases|October 16, 2014
Modeling the dynamics of oral poliovirus vaccine cessationKimberly M Thompson, Radboud J Duintjer Tebbens
Pageof 7